Regaining the response to erythropoietin following azacitidine in chronic myelomonocytic leukemia previously evolved from refractory anemia

Lignende værker

• Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome
  af: Niscola, Pasquale, et al.
  Udgivet: (2013)
• Azacitidine in Chronic Myelomonocytic Leukemia: An Effective and Manageable Approach
  af: Tendas, Andrea, et al.
  Udgivet: (2014)
• Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy
  af: Niscola, Pasquale, et al.
  Udgivet: (2014)
• Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent
  af: Niscola, Pasquale, et al.
  Udgivet: (2015)
• Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy
  af: Niscola, Pasquale, et al.
  Udgivet: (2014)